Sept 30 (Reuters) – The U.S. Food and Drug Administration has approved Novartis' oral treatment for patients with type of chronic inflammatory skin disease, the company said on Tuesday. (Reporting by Siddhi Mahatole in Bengaluru; Editing by Sahal Muhammed)
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
New Delhi [India], May 11: Dr.Harvansh Chawla, a distinguished legal expert and leader in international trade…
Sikkim [India], May 11: A new academic season is set to begin at MIT University Sikkim,…
Bengaluru (Karnataka) [India], May 11: Kennametal India Limited (KIL) reported revenues of ₹4031 million for…
Mumbai (Maharashtra) [India], May 8: The teaser of the much-awaited Hindi film Krishna Aur Chitthi…
Mumbai (Maharashtra) [India], May 9: A special book discussion and intellectual seminar on “Shatayu Sangh…
Mumbai (Maharashtra) [India], May 11: The film is produced by Nitin Narayanji Bhanushali and Vaishali…